Answers are grounded in this paper and cite their sources.
Thirty-two patients with advanced Hodgkin's disease (predominantly Stage IV), who had negative skin test responses to second strength PPD, were vaccinated with BCG during a period of quiescent or mildly active disease. Of 8 whose tuberculin responses were not converted, 7 died of Hodgkin's disease within a year. In contrast, only one of the 24 patients who developed positive tuberculin skin tests died within this time period, and the median survival of the converted group, currently 30 months, is still increasing. This difference is significant (p <.001) and indicates that BCG vaccination can provide valuable prognostic information in advanced Hodgkin's disease. It is suggested that cellular immune mechanisms may constitute the principal determinant of “host resistance” in Hodgkin's disease.
No takes yet. Share an insight, caveat, or question.
Sokal et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: